| |
Control group |
Soriatane -treated group |
| Villus loss |
0.07 ±0.32 |
2.52 ±0.71* |
| Villus shortening |
0.03 ±0.42 |
3.40 ±0.70** |
| Villus fusion |
0.06 ±0.32 |
2.70 ±0.68** |
| Microvilli damage |
0.07 ±0.32 |
2.50 ± 0.53* |
| Cellular infiltration |
0.10 ±0.12 |
2.70± 0.80** |
|
*Significant (P < 0.05) high significant **p < 0.01.
L.S. 0: non; 1: scare; 2: moderate; 3: sever; No. of individual = 7 |
| Table 3: Scoring values of the damage in the histopathological analysis of the
experimental groups. |
